Best Epcor Podcasts (2025)

1
Presented at ASH 2025: EPCORE CLL-1 trial on epcoritamab monotherapy for Richter transformation 14:22

Play Pause

17d ago14:22

14:22

Arnon Kater joins Daniela Marin of The Lancet Haematology to discuss the phase 1b/2 EPCORE CLL-1 trial of epcoritamab monotherapy for Richter transformation, which is being presented at ASH 2025. Click here to read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00327-8/fulltext Continue this conversation on soc…

1
Presented at ASH: the EPCORE FL-1 study on epcoritamab in follicular lymphoma 13:03

18d ago13:03

13:03

Franck Morschhauser joins Ben Abbott of The Lancet to discuss the phase 3 EPCORE FL-1 study on epcoritamab, lenalidomide, and rituximab for relapsed or refractory follicular lymphoma, which is being presented at ASH 2025. Click here to read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02360-8/fulltext Continu…

1
In Development Episode 66 - A New Don: Reflections on Edmonton's Past & Future Development with Former Mayor Don Iveson 1:14:49

5d ago1:14:49

1:14:49

In this episode of In Development, our hosts chat with Don Iveson, a former city councillor, mayor and current housing & sustainability expert. They discuss the historical context of Edmonton's infill policy environment, challenges we continue to face and how a better future will require collaboration between all orders of government. Don's deep kn…

1
Susannah Stanway on the London Global Cancer Week 24:04

6d ago24:04

24:04

In Conversation with The Lancet returns with Dr Susannah Stanway, honorary consultant medical oncologist at the Royal Marsden and honorary clinical senior lecturer in Education at the Institute of Cancer Research, reflecting on London Global Cancer Week 2025. This episode goes beyond event highlights to discuss the need for a global oncology agenda…

1
Carlos Monteiro, Camila Corvalán, and Phil Baker on Ultra-Processed Foods and Human Health 1:01:17

16d ago1:01:17

1:01:17

Ultra-processed foods are on the rise. Despite the emphasis placed on individual responsibility, our deteriorating diets are primarily the result of the sophisticated political tactics of a powerful global ultra-processed food industry. Addressing this urgent threat demands a coordinated response from the global public health community. So argues a…

1
ASH 2025 Preview - Expert Roundtable 22:12

23d ago22:12

22:12

Khaled Musallam, Bethany Samuelson Bannow, Mohamad Mohty, David Sallman, and Anna Sureda join us to share their expectations for the upcoming ASH 2025 congress, to be held from 6 to 9 December 2025 in Orlando, on classical and malignant haematology. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://i…

1
Arnon Kater and Sabina Kersting on the HOVON 158/NEXT STEP phase 2 trial testing a new first-line treatment regimen for chronic lymphocytic leukaemia 24:24

24d ago24:24

24:24

Professor Arnon Kater and Dr Sabina Kersting join us to discuss the results of their phase 2 trial testing a new first-line treatment regimen in chronic lymphocytic leukaemia: fixed-duration ibrutinib–venetoclax followed by MRD-guided ibrutinib–obinutuzumab intensification. Click here to read the full article: https://www.thelancet.com/journals/lan…

1
In Development Episode 65 - Edmonton Design Week & High Quality Urban Design with Peter Spearey and Eleanor Mohammad 42:57

1M ago42:57

42:57

In this episode, Eleanor Mohammed and Peter Spearey join our host Stephen to discuss the Edmonton Design Awards, great examples of urban design and its importance to building great public spaces. Learn about the jury process, philosophy and goals of Edmonton Design Week and how our guests see it evolving over time. Biographies: Peter Spearey Peter …

1
Ruben Mesa on ropeginterferon alfa-2b for hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia 11:45

2M ago11:45

11:45

Dr. Ruben Mesa (Executive Director of the Wake Forest Baptist Comprehensive Cancer Center) joins us to discuss the results of a multicentre, open-label, randomised, active-controlled, phase 3 study of ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia. Click here to read the full article Continue …

1
In Development Episode 64: Pontifications on Planning & Pedagogy with Neal LaMontagne 48:03

2M ago48:03

48:03

Register for the IDEA Symposium: https://www.eventbrite.ca/e/1571928493439?aff=oddtdtcreator Register for the Celebration of Planning: https://www.albertaplanners.com/civicrm/event/info?id=750&reset=1 In this episode, our hosts chat with Neal LaMontagne, professional planner & academic about his perspectives on planning and pedagogy. Learn about th…

1
Presented at ESMO: the HARMONi-6 study on a bispecific antibody therapy for squamous NSCLC 20:43

2M ago20:43

20:43

Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being presented at ESMO 2025. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ …

1
Presented at ESMO: the POTOMAC study on immunotherapy in non-muscle-invasive bladder cancer 22:09

2M ago22:09

22:09

Neal Shore joins Ben Abbott of The Lancet to discuss the phase 3 POTOMAC trial of durvalumab plus BCG in BCG-naïve, high-risk non-muscle-invasive bladder cancer, which is being presented at ESMO 2025. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/…

1
In Development Episode 63: Reclaiming Resources from Redevelopment with Jay Sanderson of Backroads Reclamation 44:51

3M ago44:51

44:51

With Stephen on vacation, Allison hosts this week's episode with IDEA's Executive Director Sean. The hosts chat with IDEA board member Jay Sanderson of Backroads Reclamation about the hidden goldmine of usable wood in structures poised for demolition. We learn about the complexity of building a cost-effective supply chain and removing friction from…

1
A panel of the authors on our Lancet Haematology-Lancet Regional Health Western Pacific Series on mature T-cell and natural killer-cell lymphomas 17:58

3M ago17:58

17:58

Today, on World Lymphoma Awareness Day, Professors Yok Lam Kwong, Wee Joo Chng, and Eric Tse join us in this joint episode of The Lancet Haematology and The Lancet Regional Health - Western Pacific to discuss their recent Series on advances in genomic techniques that have transformed the diagnosis, prognosis, and targeted treatment of mature T-cell…

1
In Development Episode 62: The Data V.S. the Narrative of Incremental Growth with Jacob Dawang 47:25

4M ago47:25

47:25

In this episode, Jacob Dawang of Grow Together YEG chats with our hosts about how the data of infill development tells a different story than one might expect about Edmonton's recent growth. Learn about how restrictive zoning practices have shaped cities in North America and some ideas of how we can create a better path forward. Biography: Jacob Da…

1
Lan-Lan Smith, Cheryl Lai, and Daniela Marín discuss the EHA, ICML, and ISTH conferences 19:10

5M ago19:10

19:10

June has been packed with interesting haematology conferences so the editorial team behind The Lancet Haematology have gathered to share their thoughts and reflect on their experiences at the European Hematology Association, International Conference on Malignant Lymphoma, and International Society on Thrombosis and Haemostasis meetings. Read our co…

1
Stephen Chan on the Lancet Commission on addressing the global hepatocellular carcinoma burden 20:41

5M ago20:41

20:41

With the global burden of liver cancer growing, The Lancet has commissioned an international panel of experts to identify strategies to strengthen the prevention, surveillance, diagnosis, and treatment of liver cancer. Stephen Chan joins Ben Abbott of The Lancet to discuss the key messages of the Commission, which is published today on World Hepati…

1
Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus 27:15

5M ago27:15

27:15

Early detection of oesophageal adenocarcinoma improves outcomes. Patients with the precursor lesion, Barrett's oesophagus, are recommended to undergo regular endoscopic surveillance, a process that can be burdensome for patients and health services. Professor Rebecca Fitzgerald's team have developed a tool that may be able to improve Barrett's surv…

1
In Development Episode 61: Infill, Politics and Change Management with Councillor Sarah Hamilton 1:03:07

6M ago1:03:07

1:03:07

In this episode of In Development, our hosts chat with Councillor Sarah Hamilton who reflects on her two terms in Council, shares insights about regulatory change management and explores what other cities can teach us about Edmonton. Councillor Hamilton's Biography: Sarah Hamilton is proud to be City Councillor for Edmonton’s Ward sipiwiyiniwak. Sh…

1
Paolo Strati on off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma 21:49

6M ago21:49

21:49

Associate Professor Paolo Strati (Department of Lymphoma and Myeloma, and Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA) joins us to discuss the results of a multicentre, open-label, phase 1 clinical trial of off-the-shelf induced pluripotent stem-cell-derived natural killer-cell th…

1
A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies 40:11

7M ago40:11

40:11

With a growing number of treatment options for blood cancers, understanding the side effects from these treatments and how they affect patients is becoming ever more important. Join a panel of authors from The Lancet Haematology's latest series on Adverse Event reporting to discuss how we can improve clinical trial design and analysis, and translat…

1
ASCO 2025 Debrief 14:44

7M ago14:44

14:44

Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, and Katherine Gourd, Acting Deputy Editor at The Lancet Oncology, join Leon Terner to share some of their experiences, impressions and highlights from this year's American Society of Clinical Oncology (ASCO) conference. If you haven't already, be sure to list…

1
Presented at ASCO: the first RCT of CAR T-cell therapy in solid tumours 14:45

7M ago14:45

14:45

Changsong Qi joins Chloe Wilson and Ben Abbott of The Lancet to discuss their recently published phase 2 randomised controlled trial investigating Claudin-18 isoform 2-specific CAR T-cell therapy for previously treated advanced gastric or gastro-oesophageal junction cancer. Read the full article: https://www.thelancet.com/journals/lancet/article/PI…

1
Previewing ASCO 2025 4:54

7M ago4:54

4:54

Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, joins Gavin Cleaver to discuss what's being published at this year's American Society of Clinical Oncology (ASCO) meeting, what she's excited to see at the conference, and why ASCO is so important to the field. Continue this conversation on social! Follow us …

1
In Development Episode 60: How Infill Builds Better Communities with FCX Developments' Mauricio Ochoa 48:26

7M ago48:26

48:26

In this episode, our hosts chat with Mauricio Ochoa; Vice President of IDEA and CEO of FCX Developments. Mauricio shares a behind the scenes look into his industry beginnings and explains why he is so passionate about infill. You'll learn about how he connects with neighbours and manages relationships during the development process and hear insight…

1
In Development Episode 59: The Intersection of Infill, Transit and Active Transportation with Daniel Witte and Shannon Lohner 58:13

8M ago58:13

58:13

In this episode of In Development, we explore how public and active transportation interact with infill development (and vice versa!) Our guests Daniel Witte and Shannon Lohner bring important insights from their work with Edmonton Transit Riders and Paths for People, respectively. Get ready to learn about everything from how transportation modalit…

1
Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma 15:49

8M ago15:49

15:49

Dr Michael Northend (University College London Hospitals NHS Foundation Trust, and Cancer Research UK & UCL Cancer Trials Centre, London, UK) joins us to discuss the long-term results of a randomised, phase 3 trial on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma. Read th…

1
In Development Episode 58: Exploring the Priority Growth Area Rezoning Project with The City of Edmonton's Lisa Drury 42:11

9M ago42:11

42:11

In this episode, our hosts chat with Lisa Drury from the City of Edmonton about the new Priority Growth Area (PGA) rezoning project. We dive into how the project came about, the selection process for areas being rezoned and how the public was engaged during its development. This episode provides a great opportunity to learn the nuances of the propo…

1
Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia 17:47

9M ago17:47

17:47

Dr Romy Pothof and Prof Joanne Verweij join us to discuss their development of an international consensus on the diagnosis and treatment of fetal and neonatal alloimmune thrombocytopenia. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00029-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue th…

1
Francis Couturaud on treatment of venous thromboembolism 28:30

10M ago28:30

28:30

Francis Couturaud joins Chloe Wilson of The Lancet to discuss the RENOVE trial, which looks at assessing the efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants in patients in whom extended anticoagulation has been indicated. Read the full paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02842-3/…

1
Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe 27:06

10M ago27:06

27:06

Prof Helene Schoemans, Elke Stienissen, and Kathy Goris join us to discuss the importance of consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedi…

1
In Development Episode 57: Alkarim Devani Returns to talk mddl 53:20

10M ago53:20

53:20

In this episode, we reconnect with Alkarim Devani to talk about how Edmonton and Calgary are faring when it comes to pushing for a better policy and regulatory environment with regard to infill development. We learn more about mddl, an expert organization in middle housing whose mission is to build capacity from top to bottom for "missing middle" a…

1
In Development Episode 56: How Local Coffee Shops Fit Into Infill with Antonio Gomez & Peter West 54:44

11M ago54:44

54:44

In this episode, we dive into what goes into operating that great local coffee shop that often features prominently in many visions of local redevelopment. Antonio Gomez and Peter West both operate coffee shops in Edmonton, but also have backgrounds in design and planning respectively. We chat about how community connects within coffee shops and ho…

1
Dawn Swan on air pollution and venous thromboembolism 15:02

11M ago15:02

15:02

Dr Dawn Swan joins us to discuss current knowledge and future perspectives on the possible association between air pollution and venous thromboembolism. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00291-6/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhae Continue this conversation on social! Follow u…

1
Shawn St Peter on appendicectomy versus antibiotics for acute uncomplicated appendicitis in children 16:01

11M ago16:01

16:01

This week, we discuss treatment approaches for uncomplicated appendicitis in children following the publication of a trial in our January 18th issue. Lead author Shawn St Peter, general paediatric surgeon and surgeon-in-chief at Children’s Mercy Hospital, Kansas City, spoke with Callam Davidson about the motivation behind the study, key findings, a…

1
Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis 16:03

11M ago16:03

16:03

Dr Leslie Skeith joins us to discuss the PARTUM pilot trial, comparing low-dose aspirin versus placebo in postpartum venous thromboembolism. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00338-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us today at..…

1
Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease 21:35

12M ago21:35

21:35

Michael Heneka joins Chloe Wilson and Bea Gomez Perez-Nievas of The Lancet to discuss a therapeutics paper discussing the opportunities and challenges of passive anti-amyloid β immunotherapy in Alzheimer's disease. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01883-X/fulltext?dgcid=buzzsprout_icw_podcast…

1
In Development Episode 55: Who Will Be “Sleighed” By Our Year-End Trivia Challenge? 57:08

1y ago57:08

57:08

Join us for a special year-end episode of In Development as we reflect on 2024 and look ahead to 2025. In this engaging and competitive episode, our new podcast host Stephen challenges our existing hosts to a heart-pounding elimination challenge to find out which one of them will remain in the new year. Topics include... Edmonton’s new Zoning Bylaw…

1
Neema Mayor and Caitlin Farrow on impact of patient ethnicity on haematopoeietic cell transplantation outcome in the United Kingdom 17:53

1y ago17:53

17:53

Dr Neema Mayor and Dr Caitlin Farrow from the Anthony Nolan Research Institute join us to discuss the findings of their study on the impact of patient ethnicity on haematopoietic cell transplantation outcomes in the United Kingdom. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00312-0/fulltext?dgcid=buzzs…

1
In Development Episode 54: River Valley Vitalization with Jay Downton and Erin Murray-Green of River Valley Co. 1:10:43

1y ago1:10:43

1:10:43

This episode features two passionate Edmontonians, Jay Downton and Erin Murray-Green, who are involved with River Valley Company and River Valley Hospitality. These ventures focus on creating community-oriented amenities in Edmonton’s river valley, including the beloved Little Brick Café and Umpreheville Block. Jay and his team are helping to build…

1
Nusrat Husain, Farah Lunat, and Fehmida Motala on postnatal depression in British south Asian women (the ROSHNI-2 trial) 48:44

1y ago48:44

48:44

ROSHNI-2 was a multicentre, randomised controlled trial that investigated the efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women. Joining us to share their expertise and perspectives are chief investigator Professor Nusrat Husain, trial manager Farah Lunat, and se…

1
In Development Episode 53: Moving Mountains for Missing Middle with Matthew Kennedy of Studio North 1:10:45

1y ago1:10:45

1:10:45

This episode’s guests visit us virtually from Calgary for a discussion all about building missing middle housing across Alberta. Studio North’s Matt Kennedy discusses building missing middle housing in the mountains and translates lessons learned from this context to apply across the province. Matt shares more about the Astor project in Banff, whic…

1
Rasha Al-Lamee and Shayna Chotai on ESC 2024 highlights 40:18

1y ago40:18

40:18

Rasha Al-Lamee and Shayna Chotai join Chloe Wilson of The Lancet to discuss ESC Congress 2024 highlights. The papers featured on this podcast are: 1) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01733-1/fulltext 2) https://www.nejm.org/doi/abs/10.1056/NEJMoa2409134 3) https://www.thelancet.com/journals/lancet/article/PIIS0140-…

1
Lancet Haematology 10 year anniversary - meet the editors 47:21

1y ago47:21

47:21

In a special 10 year anniversary podcast, Lan-Lan Smith, Yaiza del Pozo Martin, and Emma Cookson, the editorial team behind The Lancet Haematology, reflect on the last decade and give some insights into the editorial processes at The Lancet Group. Read our Editorial: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00289-8/fulltex…

1
In Development Episode 52: Saying Cheerio to Mariah Samji and Hello to Sean Sedgwick! 1:18:04

1y ago1:18:04

1:18:04

The guests on this episode of In-Development are familiar faces! Mariah Samji and Sean Sedgwick join forces to talk about the past, present, and future of IDEA. As Mariah moves on from her role as Executive Director of IDEA, she discusses the legacy and impact the organization has had on the City as well as herself personally. Sean shares what drew…

1
Dr Oriol Mitjà and Dr Hypolite Muhindo Mavoko on mpox 26:26

1+ y ago26:26

26:26

On August 14th, the World Health Organisation declared a public health emergency of international concern in relation to mpox. This was motivated, in part, by the emergence of a concerning new strain of mpox, clade 1b, which has spread rapidly across Central Africa. Joining me this week to discuss important clinical aspects of the current mpox outb…

1
Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome 8:08

1+ y ago8:08

8:08

Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndrome patients. Continue this conversation on social! Follow us today at... https://thelancet.bsky.soc…

1
Natasha Pocovi on the prevention of low back pain recurrence 23:50

1+ y ago23:50

23:50

Natasha Pocovi joins Chloe Wilson of The Lancet to discuss a trial investigating a walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack). Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00755-4?dgcid=buzzsprout_tlv_podcast_generic_lancet Continue this conv…

1
Kim Linton on follicular lymphoma 9:48

1+ y ago9:48

9:48

Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00166-2?dgcid=buzzsprout_tlv_podcast_generic_lanhae Continue this conversation o…

1
Judy Truong on ferritin reference levels and iron deficiency 11:17

1+ y ago11:17

11:17

Dr Judy Truong join us to discuss ferritin reference intervals and how adoption of evidence-based ferritin clinical decision limits can help clinicians detect and treat iron deficiency, minimising propagation of related health inequity and social injustice in medicine. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS235…